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Abstract
Pulmonary embolism is an acute emergency due to the occlusion of the 
pulmonary arteries by a venous blood clot. The pathophysiology of pulmonary 
embolism follows Virchow's triad, which encompasses stasis in veins, increased 
coagulation, and vessel wall trauma. Pregnancy, major trauma or surgery, pro-
longed immobilization, obesity, medication, and inherited risks are important 
risks. It is an essential rule-out diagnosis in chest pain and dyspnea patients in 
the emergency room. It is also responsible for significant mortality if not diag-
nosed and treated promptly. Physicians utilize multiple algorithmic scores and 
calculators to supplement diagnosis along with a high degree of clinical suspicion 
at initial presentation. Clinical diagnosis involves utilizing multiple modalities, 
including D-dimer, troponin, arterial blood gas analysis, electrocardiogram, 
bedside echocardiogram, and imaging modalities such as venous duplex, chest 
computed tomography, ventilation-perfusion scans, and pulmonary angiogram. 
Some imaging modalities carry the risk of radiation and being invasive. The 
treatment can itself be short-term or lifelong based on the causative factor. 
Anticoagulants used in the therapy can itself cause devastating complications if 
not monitored appropriately. Despite adequate treatment, some of these patients 
progress to chronic disease resulting in secondary pulmonary hypertension.
Keywords: Pulmonary embolism, diagnosis, computed tomography, risk factors
1. Introduction
Acute Pulmonary embolism (PE) is an emergency. It needs immediate clinical 
evaluation for appropriate recognition due to the availability of appropriate thera-
peutic interventions to decrease its immediate mortality and avoid postthrombotic 
complications. Clinical manifestations of a patient coupled with the risk factors 
at initial presentation should guide to PE suspicion. In cases where the clinical 
scenario is not straightforward, multiple algorithmic score models should promptly 
guide the physician to diagnose PE. PE diagnosis is accomplished with the help of 
multiple imaging studies, of which chest computed tomography (CT) is the one 
used frequently. In this topic, we will glean over all the factors that help in diagnos-
ing an acute PE.
2. Epidemiology
Acute pulmonary embolism (PE) is an acute critical clinical condition character-
ized by the propagation of blood clots from peripheral veins or systemic circula-
tion to the lung vasculature affecting the alveolar gas exchange. Acute PE can be 
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symptomatic or silent. The thrombus responsible for PE often originates from leg 
veins, especially the deep calf veins, followed by proximal dispersion to popliteal 
and femoral veins [1]. Thrombus at popliteal vein and proximal to it are at a high 
risk of embolic phenomenon resulting in acute PE. A non-propagating deep  
calf vein thrombus increases recurrence rate and the likelihood of postphlebitic 
complication [2]. A thrombus from the upper extremity is often due to intravascular 
venous catheters, cardiac devices, effort thrombosis, or thoracic outlet obstruction 
[3]. Pelvic veins represent another source of emboli in patients with recent pelvic 
surgery, pregnancy, infection, or prostate disease. Rarely pulmonary vascular 
occlusion occurs due to nonthrombus etiology such as parasites (schistosomiasis), 
sickled erythrocytes (sickle cell disease), talc (illicit drugs), air (central lines), or 
tissue (amniotic fluid or fat embolism).
Earlier clinical literature suggested PE as an underdiagnosed condition; how-
ever, recent studies indicate it to be an excessively diagnosed condition due to the 
introduction of modern imaging techniques in detecting PE [4, 5]. Newer studies 
indicate an increased incidence at >113 cases per 100,000 population [5]. Another 
reason is defensive medicine, as the inability to identify a clinically symptomatic 
patient could turn out to be a malpractice issue as only 8% die with appropriate 
therapy, and the figure is 30% with no therapy [6–8]. Even with an increased 
incidence, the overall mortality rate has remained the same, declining case fatality 
rates [5]. The DVT/PE incidence rate in the United States of America (USA) yearly 
is 600,000 patients per year [9]. Approximately 30% of these patients die within 
the next 3 months (180,000 per year) [4]. In medical or surgical intensive care units 
(MICU/SICU), deep vein thrombosis (DVT) occurs in 30% of patients [10, 11]. In 
an extensive registry of diagnosed DVT patients, PE was seen in 29% in the lower 
extremity(LE) and 9% in the arms [12]. PE occurrence was similar in these groups 
on observing them over the next 90 days. PE is a frequent preventable mortality 
source in hospitalized patients [13]. Despite anticoagulant therapy in critically 
ill, acute PE is linked with considerable morbidity and mortality due to a limited 
cardiopulmonary reserve [14]. After the acute critical episode, patients who make 
it out are at higher risk of type four pulmonary hypertension and postthrombotic 
syndrome. A recent study confirms that after 6 months of a PE episode, dissolu-
tion of the entire clot was observed in 50% of patients, and the remaining still had 
lingering occlusion [15, 16].
3. Clinical features
Symptomatic patients with acute respiratory failure should increase diagnostic 
possibility if they have risk elements. These risk factors have been mentioned in 
Table 1 [1, 13, 14].
Clinical features depend on the patient’s physiologic response to the venous 
thrombus, especially cardiopulmonary reserve, and vary from asymptomatic to hemo-
dynamic instability and death. An excellent clinical history can reveal risks, including 
hormone replacement therapy, bed rest, air or road travel, oral contraceptive use, 
and other comorbid conditions. Clinical symptoms include acute respiratory distress 
(most common), chest discomfort, dry cough, fever, leg swelling with or without 
pain, bloody expectoration, and rarely syncopal episode. The physical examination 
can reveal tachycardia, tachypnea, hypotension, phlebitis, rales, a loud P2, and an S4. 
It may also reveal other signs indicative of risk factors. Of the above clinical features, 
only three can distinguish between positive and negative PE based on angiogram, 
including rales, a loud P2, and S4 [17]. Clinical presentation to a hospital is seen 
via five different syndromes, which include 1) Pleuritic chest discomfort or bloody 
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expectoration, 2) Shortness of breath only, 3) Hemodynamic instability, 4) Subclinical 
clot, 5) Chronic non-resolving clot [1, 17]. The fourth and fifth clinical syndrome 
may be identified incidentally on the imaging studies while working for dyspnea of 
unknown origin or as a study to rule out other clinical conditions.
4. Non-imaging modalities
A complete blood cell count can disclose leukocytosis, while a peripheral 
smear and a differential count can reveal leukemia, myeloproliferative disorders, 
or other hematological conditions. NLR (Neutrophil to lymphocyte ratio) and 
PLR (platelet to lymphocyte ratio) if elevated at PE diagnosis signify an elevated 
short-term risk and overall mortality; however, the exact cutoff for NLR and PLR 
is yet to be decided. Both NLR and PLR can serve as cheap prognostic indicators in 
acute PE [18]. Acute PE causes myocardial distension and stretching, leading to an 
increase in BNP (Brain Natriuretic Peptide) and NT-proBNP (N-terminal pro-brain 
Natriuretic Peptide). The right ventricle (RV) undergoes significant strain during 
an acute massive PE, resulting in RV ischemia that can be small and cause elevated 
troponin and H-FABP (heart-type fatty acid-binding protein levels). Elevated 
above-mentioned cardiac biomarkers and troponin in nonmassive PE signify higher 
short-term mortality and PE-related adverse events [19, 20]. Also, in nonmassive 
PE, RV dysfunction correlated appropriately with short-term mortality [20]. 
Arterial blood gases (ABG) reveal hypoxemia in acute PE, which can worsen with 
increased PE size. PE leads to increased dead space ventilation and hypercapnia; 
however, this is seen in patients with limited ventilatory reserve or mechanically 
Acquired Inherited
A. Immobilization 1. Factor V Leiden mutation
Bed rest due to hospitalization or stroke 2. Prothrombin gene mutation
Air travel 3. Antithrombin III deficiency
Post-operative: Hip/Knee/Trauma/Spinal 4. Protein C deficiency
Morbid Obesity 5. Protein S deficiency
Comorbidities: Heart failure, Obstructive lung disease, elderly, prior 
stroke
6. Dysfibrinogenemia





Polycythemia vera, Essential thrombocytosis
Leukemia, Paroxysmal Nocturnal Hemoglobinuria
Antiphospholipid antibody syndrome
D. Others
Nephrotic syndrome, Inflammatory Bowel disease
Malignancy
Table 1. 
Risk factors for DVT/PE.
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ventilated patients [1]. In an earlier study, a 100% NPV (negative predictive value) 
for PE correlated with respiratory rate < 20 per minute, normal D-dimer level, and 
partial pressure of oxygen ≥80 mmHg [21]. This was later found to have an NPV of 
95% in a more extensive study where multiple ABG prediction rules were assessed 
and were found to lack adequate NPV, likelihood ratios, or specificity [22]. Thus 
ABG has minimal conclusive value in suspected PE patients and is inadequate to 
diagnose or exclude PE.
D-dimer presence in blood indicates intrinsic fibrinolysis by plasmin. In DVT, 
D-dimer elevation is lesser than that seen in PE due to the smaller size of the 
thrombus. Thus D-dimer sensitivity is higher in PE (> 95%) than in DVT (>80%) 
[13]. The D-dimer elevation is observed in infection, inflammation, ischemia, 
cancer, trauma, and postoperatively making it a nonspecific test. Thus its predic-
tive role in hospitalized patients is minimal. D-dimer is outstanding in patients 
<65 years of age plus lower pretest PE probability. D-dimer had a diminishing value 
in the patient subset >65 years of age due to more false positives [23]. Another 
study suggested using age-adjusted D-dimer testing alongside Well’s score as it 
improved efficiency with no effect on safety in all subgroups studied. The efficiency 
was notably observed in elderly patients, patients with cancer, obstructive lung 
disease, prior venous thromboembolism, or a late presentation [24]. A standardized 
hypersensitive negative test result safely rules out PE among mild or moderate-risk 
patients [1].
In a small proportion(10–25%) of PE patients an ECG (electrocardiogram) is 
normal [25]. ECG can reveal multiple findings that lack sensitivity and specificity 
individually to diagnose PE. The commonest ECG finding is acute sinus tachycardia 
[26]. Other significant ECG findings are mentioned in Table 2 below [27].
In an established extensive PE, a frequent earlier finding is precordial T wave 
inversions [28]. The observation of S1Q3T3, RBBB, and inverted T waves (V1-V4 
leads) in a PE patient’s ECG indicated RV dysfunction [28, 29]. V1 to V3 precordial 
lead T wave inversions had a higher true positive rate and diagnostic accuracy than 
S1Q3T3 and RBBB findings in RV dysfunction detection in acute PE [30]. If ECG 
reveals an RV strain pattern, the patient is at a higher mortality risk and adverse out-
comes, despite being hemodynamically stable [31]. RBBB, Lead V1 ST-segment eleva-
tion, and low voltage QRS complexes are observed in PE patients with cardiogenic 
shock [32]. The following findings were frequently seen in patients who had a fatal 
outcome after a PE, including complete RBBB, atrial arrhythmias, Q wave (leads III 
& aVF), Peripheral small amplitudes, and left precordial ST changes. In a study, 29% 
of patients with these ECG findings did not make it out of the hospital on discharge 
[33]. A concurrent occurrence of inverted T waves in leads II, III, aVF, and V1 to V4 
is highly distinct for PE (99%) than ACS but uncommon [34]. Acute PE accurately 
1. Acute sinus tachycardia
2. T wave inversions in precordial leads (V1-V4)
3. S1Q3T3 sign (Lead I S wave, Lead III Q wave, and a Lead III inverted T wave)
4. Atrial arrhythmias
5. RBBB (Right bundle branch block)
6. Low amplitude QRS complexes
7. ST-segment elevation in leads V1 and aVR
8. Q wave (Leads III and aVF)
Table 2. 
ECG findings in acute PE.
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distinguishes from ACS by the presence of lead III and V1 T wave inversions on ECG 
[35]. An essential role of performing an EKG in acute PE is its help in ruling out other 
differential diagnoses, such as ACS, myocarditis, or acute pericarditis.
5. Noninvasive imaging modalities
Venous duplex ultrasound uses the ability to detect venous blood flow and 
real-time B-mode images to identify clots in both upper and lower limbs [36]. The 
specific diagnostic DVT criteria include the following, lack of venous segment 
collapse on pressure (more specific), respiration induced loss of phase changes, 
a weak venous response to Valsalva, echogenic substance in the lumen, loss of 
increase in flow due to compression, and loss of flow or decreased flow on color 
Doppler [1]. In symptomatic patients, duplex ultrasonography sensitivity and 
specificity in diagnosing DVT are higher than in asymptomatic patients (lesser 
accuracy). While 30–40% of PE patients are clinically symptomatic for proximal 
DVT, the venous duplex can detect proximal DVT in 60–80% of PE patients [37]. 
In postoperative orthopedic patients, the performance of venous duplex ultrasound 
was comparable to contrast venography in asymptomatic proximal DVT detection 
[38]. Asymptomatic DVT in contralateral LE was seen in 5–10% of patients with 
acute symptomatic DVT [39]. Duplex ultrasonography accuracy in identifying deep 
calf vein limited DVT, and asymptomatic proximal vein DVT is limited in high-risk 
populations [40]. After an initially negative result in suspected DVT patients, serial 
duplex ultrasonography can detect the proximal extension [41].
The sensitivity of detecting PE via TTE (transthoracic echocardiogram) is only 
50%, so it is a poor imaging modality for acute PE diagnosis [42]. RV pressure 
or volume overload suggestive of PE can guide PE diagnostic imaging without 
other differentials [1]. TTE can reveal the McConnell sign (RV mid-free wall lack 
of movement with no apex involvement) [43]. On rare occasions, emboli can be 
visualized in the right heart on TTE. TTE based risk assessment helps in guiding 
acute PE therapy. Patients with RV dysfunction on TTE in a normotensive patient 
indicate adverse outcomes or early mortality [44, 45]. An appropriately done TEE 
(transesophageal echocardiogram) can detect central PE (Pulmonary artery and 
its branches) with a true positive and negative rate > 90% [46]. It is an excellent 
modality to consider in a speculated massive PE patient hemodynamically unstable 
for transport or has contrast contraindication. TTE helps ward off other differential 
diagnoses, including infective endocarditis, pericardial effusion or tamponade, 
aortic dissection, and RV myocardial infarction. Significant changes seen on a TTE 
are mentioned below in Table 3 [47].
A meta-analysis assessed multiple echo studies and consistently showed that 
TTE had a greater specificity and sensitivity for PE diagnosis and is a definitive 
rule in test at the bedside for suspected patients [47]. As per ACEP guidelines, the 
presence of an RV dysfunction on TTE in an unstable patient can suggest acute PE 
and an indication for thrombolytic therapy [48].
A positive or negative transthoracic lung ultrasound (TLS) can cause an incre-
ment or decrement in PE probability by 30% in a moderate risk population, which 
can change the diagnostic workup [49]. TLS can detect smaller PE in the periphery 
of the lungs [50]. Most emboli are observed in the lower lungs, which can be easily 
accessed by TLS [51]. An endobronchial ultrasound (EBUS) can detect central PE 
and immensely help PE patients with AKI, contrast contraindication, pregnancy, 
and hemodynamically unstable patients with diagnosis [52–54]. Simultaneously 
it can measure the acutely elevated pulmonary hypertension in patients with PE. 
Endobronchial ultrasound findings can supplement TLS in acute PE detection [49]. 
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However, the resources required (regular bronchoscope, trained nursing staff) to 
perform a bedside bronchoscopy with EBUS makes it challenging to achieve in the 
emergency department or the MICU on an as-needed basis. Performing a bron-
choscopy in a hemodynamically unstable patient may worsen the patient’s overall 
cardiopulmonary status and increase his high risk of adverse outcomes.
A meta-analysis revealed that cardiopulmonary ultrasound (CPUS) sensitivity 
was 91% and specificity was 81% for PE diagnosis in comparison to CT pulmonary 
angiography (CTPA) [55]. The BLUE (bedside lung ultrasound in emergency) pro-
tocol was made to diagnose PE based on a DVT positive venous duplex combined 
with TLS. It was 99% specific and 81% sensitive for PE diagnosis and ruled out 
other acute respiratory failure differentials [56]. BLUE protocol and TTE consis-
tently revealed a greater specificity than sensitivity due to the lack of ruling PE out 
with no CTPA [56, 57]. The combination may help in decreasing the excessive CTPA 
done currently [58]. In resource-limited settings such as in developing countries or 
the absence of CTPA availability, CPUS may have a role in managing PE [55].
Chest X-ray can either be normal or abnormal. Most often, a chest X-ray reveals 
nonspecific abnormal findings such as effusion, infiltrates, or atelectasis. Certain 
signs with interesting names that have been observed on chest radiograph imaging 
are mentioned in Table 4 [59–61].
The occurrence of Westermark’s sign and Palla’s sign suggests embolic obstruc-
tion of either the lobar/segmental pulmonary artery/widespread small arterial 
involvement [60]. A patient with acute shortness of breath, respiratory distress, 
or hypoxia and a benign chest radiograph is suspicious of possible PE. A chest 
radiograph also helps in ruling out other causes such as empyema, pneumonia, and 
pneumothorax.
1. Increased ventricle size ratio
2. Abnormal septal motion
3. Tricuspid valve regurgitation (TVR)
4. 60/60 sign
5. McConnell’s sign
6. Right heart thrombus
7. Right ventricle hypokinesis
8. Pulmonary hypertension
9. Increased right ventricle end-diastolic diameter (RVEDD)
10. Tricuspid annular plane systolic excursion (TAPSE)
11. Increased right ventricle systolic pressure (RVSP)
Table 3. 
Distinct TTE signs seen in acute PE.
1. Westermark’s sign Localized diminished blood supply in lung
2. Hampton’s hump Pulmonary infarction distal to occluded emboli (Wedge shape)
3. Palla’s sign Distended right descending pulmonary artery or sausage appearance
4. Fleischner sign Central pulmonary enlargement
5. Knuckle sign Abrupt pulmonary artery tapering
Table 4. 
Interesting findings noted on chest-X-ray.
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After CTPA, V/Q (ventilation/perfusion) scintigraphy is an alternative utilized 
in diagnosis. V/Q scintigraphy negative or high-probability result is of critical value 
in PE diagnosis [62, 63]. A negative V/Q scan result is as efficacious as a pulmonary 
angiogram, ruling out acute PE and slightly better than a CTPA [64]. A normal 
perfusion scan sensitivity in ruling out PE is exceptional, observed even with a 
higher pretest PE probability in severely sick patients [62, 65, 66]. A meta-analysis 
validates this observation by revealing a minimal 0.3% PE incidence in individuals 
with an intact perfusion result [67]. Similarly, high-risk V/Q scintigraphy (multi-
segmental mismatch defects) correlates with acute PE in 87% of patients, and the 
positive predictive value (PPV) is increased to 96% by a higher pretest probability 
[62]. However, most suspected acute PE or PE patients do not have V/Q scan find-
ings suggestive of a high probability scan. Also, most patients with no PE did not 
have a normal V/Q result. A clinically significant portion of patients (33% = moder-
ate risk and 10% = low risk) had positive angiograms. The prospective trial PIOPED 
stressed on the number of perfusion defects and size along with a concurrent image 
to identify V/Q mismatch defects [62]. In the PISA-PED study, greater emphasis was 
placed on the perfusion defect shape than the number and size or ventilation image 
correlation [65]. The PISA-PED study confirmed that perfusion in combination 
with pretest probability in the absence of ventilation image could diagnose acute 
PE without angiography [65]. A majority of intermediate V/Q imaging results are 
observed in obstructive lung disease patients [68]. V/Q scintigraphy is favored in 
patients with renal failure, contrast allergy and offers similar diagnostic efficacy in 
pregnancy [1, 69]. The severely sick patients can undergo bedside perfusion imag-
ing to avoid transportation-associated risks [1].
SPECT-V/Q scan, a new scintigraphy process that generates 3-dimensional 
images than a planar image seen in V/Q scans. Advantages associated are better 
visualization of all perfusion defects in different lung areas, less radiation exposure 
than CTPA, fewer nondiagnostic test results (0.5–3%) [70–75]. SPECT-V/Q effi-
ciency is similar to that of CTPA in suspected acute PE patients [76]. SPECT-V/Q 
true positive and negative rates were noted to be in the range of 95–100%. [76, 77]. 
However, it cannot replace CTPA as a test of choice in acute PE due to the lack of 
vigorous extensive testing to verify its validity in suspected patients [78]. Specific 
clinical scenarios might be appropriate for using a SPECT-VQ scan, including a 
nondiagnostic CTPA study and post-discharge evaluation of lingering perfusion 
abnormalities.
The imaging modality of choice to exclude acute PE in suspected patients is CTPA. 
CTPA sensitivity is 83%, specificity is 96%, with an NPV of 97% plus a PPV of 86% 
in suspected patients [17]. CTPA sensitivity and specificity are greater than 95% in 
central PE (pulmonary artery and lobar branches) [79]. The sensitivity and specific-
ity decline gradually when the emboli involve segmental or subsegmental pulmonary 
arteries. In a study of CTPA for subsegmental artery, involvement sensitivity was 
noted in the range of 71–84% [80]. PE involving only the subsegmental arteries of the 
pulmonary circulation is seen in around 30% of PE patients [81, 82]. CTPA evaluation 
is diagnostic when emboli involve the main or lobar pulmonary arteries and is consid-
ered suggestive if the segmental and subsegmental pulmonary arteries are occluded. 
CTPA predictive value is critically hampered in discordance with clinical evaluation, 
and further imaging tests merit consideration in this scenario [1]. CTPA has its limita-
tions which are significant to be ignored. Intravenous iodinated contrast given during 
CTPA can cause AKI. CTPA cannot effectively diagnose emboli in the subsegmental 
pulmonary arteries and cannot supplement the V/Q scan, which also lacks in this 
particular territory [62, 81]. CTPA is not able to identify whether the emboli is acute, 
subacute, or chronic. CTPA occurrence results in significant radiation exposure to the 
patient, especially in young females (breast and lungs) [83]. Clinical observations have 
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suggested significant overuse of CTPA resulting in overdiagnosis of pulmonary embo-
lism; however, it cannot determine whether the positive CTPA identifies acute PE, 
subacute PE, or chronic PE [63]. A clinical study observed no substantial difference 
in results when anticoagulation was withheld in suspected individuals with a normal 
CTPA plus negative leg duplex ultrasonography and negative or non-high probable 
V/Q imaging with a negative leg venous duplex [63]. The study was performed on 
relatively stable patients, so this observation cannot be utilized in severely sick patients 
or patients with inadequate cardiopulmonary reserve [84].
A clinical trial PIOPED III evaluated a magnetic resonance angiogram for PE 
diagnosis [85]. Overall, the sensitivity to diagnose a PE involving the main and 
lobar pulmonary artery was 79%. It may be an ideal test for patients with intrave-
nous contrast allergy or to avoid radiation exposure, such as pregnancy.
6. Invasive imaging modalities
CT venography (CTV) has similar diagnostic accuracy as venous duplex ultra-
sound for the LE in diagnosing or ruling out DVT; however, the test is invasive and 
comes with exposure to contrast and radiation [86]. In addition to the LE venous 
system, vena cava and pelvic veins are visualized. CTPA and CTV combined 
revealed a mild improvement in diagnostic outcome with a substantial increase in 
cost and pelvic exposure to radiation.
Contrast venography is the best imaging study for substantiating LE venous throm-
bosis. Its diagnostic criteria include a persistent venous filling defect observed in ≥ two 
views. It is an expensive, invasive test requiring clinical expertise and accurate inter-
pretation with significant exposure to intravenous iodine contrast. Due to the above 
reasons, Venous duplex has replaced it as the test of choice to diagnose acute DVT.
Before CTPA, a pulmonary angiogram was the best imaging study to diagnose 
acute PE. It requires appropriate clinical expertise to perform the invasive proce-
dure and interpret it. Three factors determine the result, including the location 
of the emboli, image quality, and interpreter’s experience [1]. Diagnosis of PE is 
indicated by either a filling defect and/or abrupt vessel cutoff. Flow defects can be 
avoided by ensuring good vascular opacification and obtaining multiple sequences 
of films. The PIOPED trial revealed that it was diagnostic in 97% of patients and 
associated with 1% complications, including a mortality rate of 0.5% [87]. Adverse 
outcomes were significantly seen in MICU patients transported for an angiogram. A 
pulmonary angiogram is considered in a tiny patient subset when PE diagnosis can-
not be determined by noninvasive imaging studies, significant discordance between 
imaging study and clinical evaluation, and chronic thromboembolic disease.
7. Diagnostic workup
The current clinical approach for acute PE or DVT diagnosis utilizes a Bayesian 
analysis. Here pretest probability of the clinical condition is measured exclusive of 
the test outcome wire clinical means or a consistent prediction rule such as Well’s or 
Geneva score. Then a posttest probability of the clinical condition is generated by 
utilizing pretest probability combined with a test’s likelihood ratio. The posttest prob-
ability is used as guidance for clinical decision making that confirms or to excludes the 
disease with a degree of probability or helps in deciding additional imaging studies. 
Clinical predictive rules for acute DVT include the Well’s, revised Well’s, and Geneva 
scores. Well’s score classifies suspected acute DVT patients into three subclassifica-
tion’s unlikely (3%), moderate (17%), and likely (75%). With the help of Well’s score 
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and LE venous duplex ultrasound, diagnosis of acute DVT can be established in likely 
individuals with a positive LE venous duplex result. In unlikely individuals, a negative 
LE venous duplex result excludes acute DVT [88]. The revised Well’s score divided the 
patients into likely and unlikely categories. The unlikely group with a negative D-dimer 
excluded an acute DVT without needing a LE venous duplex ultrasound [89, 90].
Clinical predictive tools for acute PE include Well’s criteria, revised Geneva 
score, Pisa model, PERC (PE rule-out criteria), and Charlotte rule [91–95]. Among 
the clinical predictor rules or scores for acute PE diagnosis, Well’s score fared better 
than the revised Geneva score [96]. Most diagnostic algorithms for acute PE use 
either CTPA or V/Q scintigraphy as a first test. A diagnostic algorithm based on 
clinical probability has been described in Figure 1 below for acute PE.
Clinical predictive rules or scores are not superior to clinical assessment but 
offset the variation observed with physician judgment and experience by stan-
dardization [1]. These rules were framed for patients seen in outpatient settings 
and applicable in primary care and emergency departments; however, they fare 
poorly and lack clinical validity in hospitalized patients. In hospitalized patients, 
the clinical predictive scores or rules and D-dimer are of minimal help to make a 
clinical decision. As a result, most of these patients need an imaging study to rule in 
or exclude acute PE diagnosis [1].
8. COVID-19 infection and venous thromboembolism
Although acutely ill patients are at a higher risk of acute PE, COVID -19 (corona-
virus disease 2019) infected patients suffer from in situ immunothrombosis char-
acterized by small and medium pulmonary artery numerous thrombi occurring at 
a greater frequency (24%) than in H1N1 influenza patients [97–101]. PE phenotype 
in COVID-19 patients in comparison to others correlates with peripheral thrombotic 
Figure 1. 
Diagnostic testing of acute PE based on clinical probability.
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lesions with a lesser clot burden [102]. Pulmonary localized immunothrombosis 
in COVID-19 is a minimal addition to the overall procoagulant state resulting in 
DVT seen only in 42.4% of PE patients in COVID-19 than the 60% occurrence seen 
frequently in other PE patients [103]. D-dimer elevation in COVID-19 could be 
due to the acute infection-induced inflammation causing a procoagulant state or a 
localized micro thrombosis in the pulmonary vasculature.
D-dimer levels elevation >500 μg/L & 1000 μg/L were associated with a higher 
sensitivity (> 90%) but a lower specificity (< 30%) in PE diagnosis. D-dimer 
performance in COVID-19 is similar to that seen in other prothrombotic conditions 
[104]. COVID-19 patients on statin therapy before admission had a lower risk of 
PE occurrence [105]. COVID-19 patients with significant inflammation measured 
by elevated C-reactive protein and D-dimer were at a higher risk of acute PE [106]. 
PE was detected frequently in the periphery than in the central pulmonary arteries 
[107]. The most frequent site was the segmental, followed by the lobar, central, and 
subsegmental PE [106]. Acute PE was observed at a greater prevalence in COVID-
19 patients with an increased Body mass index (BMI) [106].
A systematic review and meta-analysis on PE and DVT in COVID-19 patients 
disclosed a higher pooled PE incidence of 24.7% in ICU patients. This percentage is 
substantially higher than the proportion seen in other viral pneumonia admitted to 
ICU in the presence or absence of acute respiratory distress syndrome (1.3%–7.5%) 
[108, 109]. In contrast, it was 10.5% in non-ICU patients (higher than the usual) 
[107]. Overall the incidence rates of PE and DVT in COVID-19 patients were 16.5% 
and 14.8% [107]. COVID -19 infection severity and CTPA universal screening 
correlated with a greater frequency of PE diagnosis. DVT was a concurrent finding 
in 42.4% of patients with acute PE. An elevated BMI (> 30) correlated substantially 
with a 2.7 times higher frequency of an acute PE [106]. As observed in a recent 
study, obese patients with COVID-19 suffer from a more severe disease [110]. A 
meta-analysis revealed an increased prevalence of venous thromboembolism and 
acute PE with increasing age in COVID-19 patients [111].
9. Conclusion
Acute PE is an emergency, and ongoing research will reveal newer biochemical 
assays and better imaging studies for accurate earlier detection of acute PE in the 
upcoming few years. SPECT V/Q scan is currently undergoing evaluation at multiple 
centers where it is being compared to planar V/Q study and CTPA in suspected PE 
patients for accuracy. Physicians must understand the fallacies of each biochemical 
test and imaging study for their appropriate utilization in a clinical scenario for the 
patient’s best outcome. Critical ECG findings and bedside echocardiogram findings 
should be stressed upon admission and utilized for prognostification. Physicians 
should be aware that these clinical scores or prediction rules play no role in hospitalized 
patients and should not be used for decision-making in this particular patient subset.
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Acronyms and Abbreviations
PE  Pulmonary embolism
CT  Computed tomography
USA  United States of America
MICU  Medical intensive care unit
SICU  Surgical intensive care unit
DVT  Deep vein thrombosis
LE  Lower extremity
P2  Pulmonic component of second heart sound
S4  Fourth heart sound
NLR  Neutrophil to Lymphocyte ratio
PLR  Platelet to Lymphocyte ratio
NT-proBNP N-terminal pro Brain natriuretic peptide
BNP  Brain natriuretic peptide
RV  Right ventricle
H-FABP  Heart-type fatty acid-binding protein
ABG  Arterial blood gas
NPV  Negative predictive value
ECG  Electrocardiogram
RBBB  Right bundle branch block
ACS  Acute coronary syndrome
TTE  Transthoracic echocardiogram
TEE  Transesophageal echocardiogram
TVR  Tricuspid valve regurgitation
RVEDD  Right ventricle end-diastolic diameter
TAPSE  Tricuspid annular plane systolic excursion
RVSP  Right ventricle systolic pressure
ACEP  American College of Emergency physicians
TLS  Transthoracic lung ultrasound
EBUS  Endobronchial ultrasound
CPUS  Cardiopulmonary ultrasound
CTPA  Computed tomography pulmonary angiography
BLUE  Bedside lung ultrasound in emergency
V/Q  Ventilation / Perfusion
PIOPED Prospective investigation of pulmonary embolism diagnosis
PISA-PED  Prospective Investigative Study of Acute Pulmonary Embolism
Diagnosis
SPECT  Single Photon Emission Computed Tomography
CTV  Computed tomography venography
PERC  Pulmonary embolism rule-out criteria
COVID-19 Coronavirus disease 2019
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